GlassScriptPhysician profile
Eiliana Bitar
NPI 1770793416
$1,397.32
in general payments reported to CMS, 2019-2025
16 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $112 · 2021: $248 · 2022: $258 · 2023: $149 · 2024: $72.56 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $655.65 | 2019-2025 | Liletta, Oriahnn, Lo Loestrin Fe |
| Amgen INC. | $121.40 | 2022 | |
| Coopersurgical, INC. | $118.43 | 2019-2025 | Paragard T 380a |
| Shield Therapeutics INC | $109.45 | 2022-2023 | Accrufer |
| Hologic Sales and Service, LLC | $71.41 | 2020-2024 | Myosure Tissue Removal Device, Acessa Provu System |
| Aspira Women'S Health INC | $68.49 | 2019-2021 | |
| Avion Pharmaceuticals | $51.13 | 2019 | |
| Sumitomo Pharma America, INC. | $48.80 | 2024-2025 | Myfembree |
| Dysis Medical, INC. | $27.26 | 2021 | |
| Scynexis, INC. | $23.24 | 2022 | |
| Astellas Pharma US INC | $19.20 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $17.94 | 2023 | |
| Baxter Healthcare | $16.74 | 2025 | Seprafilm |
| Mission Pharmacal Company | $16.67 | 2019 | |
| Novo Nordisk INC | $15.93 | 2025 | Wegovy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $15.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eiliana Bitar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.